Magnetic resonance colonography for the detection of inflammatory diseases of the large bowel: quantifying the inflammatory activity

Ajaj, W. M.; Lauenstein, T. C.; Peister, G.; Gerken, G.; Ruehm, S. G.; Debatin, J. F.; Goehde, S. C.
February 2005
Gut;Feb2005, Vol. 54 Issue 2, p257
Academic Journal
Introduction: The purpose of this study was to assess the diagnostic accuracy of magnetic resonance colonography (MRC) for its ability to detect and quantify inflammatory bowel disease (IBD) affecting the colon. Endoscopically obtained histopathology specimens were used as the standard of reference. Materials and methods: Fifteen normal subjects and 23 patients with suspected IBD of the large bowel underwent MRC. Three dimensional Ti weighted data sets were collected following rectal administration of water prior to and 75 seconds after intravenous administration of paramagnetic contrast (gadolinium- BOPTA). The presence of inflammatory changes in patients was documented based on bowel wall contrast enhancement, bowel wall thickness, presence of perifocal lymph nodes, and loss of haustral folds. All four criteria were quantified relative to data obtained from normal subjects and summarised in a single score. This MRC based score was compared with histopathological data based on conventional endoscopic findings. Results: MRC correctly identified 68 of 73 segments found to reveal IBD changes by histopathology. All severely inflamed segments were correctly identified as such and there were no false positive findings. Based on the proposed composite score, MRC detected and characterised clinically relevant IBD of the large bowel with sensitivity and specificity values of 87% and 100%, respectively, for all investigated colonic segments. Conclusion: MRC may be considered a promising alternative to endoscopic biopsy in monitoring !BD activity or assessing therapeutic effectiveness.


Related Articles

  • Perception of eye contact in video teleconsultation. Tam, Tony; Cafazzo, Joseph A.; Seto, Emily; Salenieks, Mary Ellen; Rossos, Peter G. // Journal of Telemedicine & Telecare;Jan2007, Vol. 13 Issue 1, p35 

    During patient consultations by videoconferencing, clinicians often sit as close as 1 m from the videoconferencing units, creating a significant eye gaze angle (i.e. the angle between the eye and the camera, and the eye and the centre of the display). Eye gaze angle may adversely affect the...

  • New therapeutic approach in inflammatory bowel disease. PAPA, A.; MOCCI, G.; SCALDAFERRI, F.; BONIZZI, M.; FELICE, C.; ANDRISANI, G.; GASBARRINI, A. // European Review for Medical & Pharmacological Sciences;Jan2009 Supplement, Vol. 13 Issue S-1, p33 

    In the last decade, biologic agents, in particular infliximab and adalimumab, have deeply changed the therapeutic armamentarium of inflammatory bowel disease (IBD). However, these drugs have a number of contraindications and side-effects that physicians should know so to avoid and eventually...

  • Inflammatory bowel disease posters.  // Gut;Apr2005 Supplement 2, Vol. 54, pA89 

    The article presents information on abstracts related to inflammatory bowel disease. An abstract presents information on the faecal calprotectin in the management of IBD and in the assessment of patients with LBS. Calprotectin is a neutrophil derived protein that is stable in stool. It shows...

  • Neuroinflammation in inflammatory bowel disease. Lakhan, Shaheen E.; Kirchgessner, Annette // Journal of Neuroinflammation;2010, Vol. 7, p37 

    Inflammatory bowel disease is a chronic intestinal inflammatory condition, the pathology of which is incompletely understood. Gut inflammation causes significant changes in neurally controlled gut functions including cramping, abdominal pain, fecal urgency, and explosive diarrhea. These symptoms...

  • Growth Impairment in Inflammatory Bowel Disease. Sherlock, Mary; Griffiths, Anne M. // Current Medical Literature: Growth, Growth Hormone, & Metabolism;2008, Vol. 2 Issue 2, p41 

    The article presents information on the prevalence of growth impairment in pediatric inflammatory bowel disease (IBD). It explores the patterns of growth and pubertal progression in young patients with IBD. It explains the standardized monitoring and assessment of growth. It discusses the...

  • Inflammatory Bowel Disease Part II: Crohn's Disease - Pathophysiology and Conventional and Alternative Treatment Options. Head, Kathleen; Jurenka, Julie // Alternative Medicine Review;Dec2004, Vol. 9 Issue 4, p360 

    Crohn's disease, a subcategory of inflammatory bowel disease, contributes to significant morbidity, particularly in industrialized nations. It can affect people of any age, but is more commonly diagnosed in adolescence and young adulthood. Inflammation and ulceration occur primarily in the...

  • Inflammatory Bowel Disease: Its Present and Its Future. Kirsner, Joseph B. // American Journal of Gastroenterology;Nov1989, Vol. 84 Issue 11, p1358 

    Discusses the developments in the treatment of inflammatory bowel disease (IBD) as of 2005. Experiment done to determine the treatment for IBD; Pathogenesis of IBD; Microbial cause of IBD.

  • Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage. D Foell // Gut;Jun2009, Vol. 58 Issue 6, p859 

    It is a common experience that gastrointestinal symptoms urge us to differentiate inflammatory bowel disease (IBD) from functional disorders. Furthermore, in patients with proven IBD the disease activity has to be accurately monitored. Faecal markers of neutrophil influx into the mucosa are...

  • Coping With Crohn's Disease. Waters, Jen // World & I;Jun/Jul2006, Vol. 21 Issue 6, p20 

    The article considers the cause, diagnosis and treatment of Crohn's disease. Crohn's disease is a type of inflammatory bowel disease, a family of diseases that cause irritation in the intestines. Because the occurrence of Crohn's disease parallels peptic ulcer disease, it would suggest that the...


Read the Article


Sign out of this library

Other Topics